
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is a prominent player in the tissue and hygiene market, deriving over 50% of its revenue from personal care products and an additional one-third from consumer tissue offerings, which positions it well amid ongoing consumer demand. The company is set to enhance its growth trajectory through an anticipated robust innovation pipeline in 2026, leveraging new technologies to deliver improved product offerings across its brand portfolio, including Huggies and Kleenex. Additionally, Kimberly-Clark’s strategic expansion into Kenvue's consumer health portfolio by the second half of 2026 is expected to further augment its market presence and revenue diversification.
Bears say
Kimberly-Clark is projecting a significant organic sales decline of -4.0% for the third quarter of 2025 in North America, a notable revision from a previously anticipated growth of +4.5%. Additionally, the company has experienced a -2.7% decline in US measured retail sales, indicating continued challenges in the consumer market. Furthermore, there has been a reduction in future earnings per share estimates, lowering the fiscal 2025 expectation from $7.60 to $7.41 and the 2026 expectation from $8.00 to $7.85, reflecting a deteriorating financial outlook.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares